Importance of biomarkers in risk stratification of pulmonary thromboembolism patients.

INTRODUCTION Patients with pulmonary thromboembolism (PTE) are classified into 3 groups according to the clinical risk factors associated with mortality. High-risk patients and some of the intermediate-risk patients should be treated immediately to decrease the high mortality risk. Although clinical risk level of PTE can be determined by using… (More)